CCP's WuXi AppTec May Be Affected as the US Plans to Introduce the “Biosecure Act”

03/25/2024 Bloomberg Television: The US draft law Biosecure Act is casting a cloud over some Chinese pharma firms. It aims to block certain foreign biotech companies from accessing US federal contracts on national security grounds. But it's not just the individual health of Americans and the national security, there's also the economic benefit. Because CCP has really focused on biotechnology as an industry of the future and wants to have a key role in it, but the world leader the US does not want to give an inch.
03/25/2024 彭博电视台：美国的《生物安全法案》草案给一些中国制药公司蒙上了阴影。该法案出于国家安全考量，旨在阻止某些外国生物技术公司获得美国联邦合同。但这不仅只关系到美国人的健康和国家安全，还有经济利益方面的考量。因为中共已将生物技术视为未来产业的重点，并希望发挥主导作用。但该领域的世界老大美国却不想让步。